Ibandronate + Vitamin Supplements
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Hematological Malignancies
Conditions
Hematological Malignancies
Trial Timeline
Dec 9, 2008 → Apr 7, 2017
NCT ID
NCT00824993About Ibandronate + Vitamin Supplements
Ibandronate + Vitamin Supplements is a phase 3 stage product being developed by Roche for Hematological Malignancies. The current trial status is completed. This product is registered under clinical trial identifier NCT00824993. Target conditions include Hematological Malignancies.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00824993 | Phase 3 | Completed |
Competing Products
20 competing products in Hematological Malignancies